title: Reply: Adding Ezetimibe to Simvastatin for the Secondary Prevention of Cardiovascular Disease: Is it Useful?
authors.forename: Sabina A
authors.initials: SA
authors.lastname: Murphy
authors.forename: Christopher P
authors.initials: CP
authors.lastname: Cannon
authors.forename: Michael A
authors.initials: MA
authors.lastname: Blazing
authors.forename: Robert P
authors.initials: RP
authors.lastname: Giugliano
authors.forename: Andrew M
authors.initials: AM
authors.lastname: Tershakovec
authors.forename: Eugene
authors.initials: E
authors.lastname: Braunwald
mesh_terms: D000924:Anticholesteremic Agents; D002318:Cardiovascular Diseases; D008078:Cholesterol, LDL; D004359:Drug Therapy, Combination; D000069438:Ezetimibe; D006801:Humans; D006937:Hypercholesterolemia; D055502:Secondary Prevention; D019821:Simvastatin
chemical_list: D000924:Anticholesteremic Agents; D008078:Cholesterol, LDL; D019821:Simvastatin; D000069438:Ezetimibe